4th Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, annual payment updates, and Part D formulary issues. Support for H.R. 4190, a bill that would amend title 18 of the Social Security Act to provide for coverage of pharmacist services under the Medicare Program.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4190 (113th)

Pharmacy PHA

Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning the Drug Quality and Security Act, all titles. Communication with the FDA on labeling of generic medications and biosimilars.

LobbyistCovered position, as disclosed
NICHOLAS GENTILE —
JOSEPH M HILL —
BRIAN M MEYER —
CHRISTOPHER J TOPOLESKI —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.